| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.093 | 0.002 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |